Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. (s)-7-(5-methylfuran-2-yl)-3-((6-(((tetrahydrofuran-3-yl)oxy)methyl)pyridin-2-yl)methyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidin-5-amine
2. Cpi-444
1. Cpi-444
2. 1202402-40-1
3. V81444
4. Ciforadenant [inn]
5. Cpi444
6. V-81444
7. Ciforadenant [usan]
8. 8kfo2187cp
9. (s)-7-(5-methylfuran-2-yl)-3-((6-(((tetrahydrofuran-3-yl)oxy)methyl)pyridin-2-yl)methyl)-3h-[1,2,3]triazolo[4,5-d]pyrimidin-5-amine
10. 7-(5-methyl-2-furanyl)-3-[[6-[[[(3s)-tetrahydro-3-furanyl]oxy]methyl]-2-pyridinyl]methyl]-3h-1,2,3-triazolo[4,5-d]pyrimidin-5-amine
11. Ciforadenant (usan)
12. 3h-1,2,3-triazolo(4,5-d)pyrimidin-5-amine, 7-(5-methyl-2-furanyl)-3-((6-((((3s)-tetrahydro-3-furanyl)oxy)methyl)-2-pyridinyl)methyl)-
13. 7-(5-methylfuran-2-yl)-3-[[6-[[(3s)-oxolan-3-yl]oxymethyl]pyridin-2-yl]methyl]triazolo[4,5-d]pyrimidin-5-amine
14. Cpi 444
15. (s)-7-(5-methylfuran-2-yl)-3-((6-(((tetrahydrofuran-3-yl)oxy)methyl)pyridin-2-yl)methyl)-3h-(1,2,3)triazolo(4,5-d)pyrimidin-5-amine
16. Ciforadenant [usan:inn]
17. Unii-8kfo2187cp
18. V 81444
19. Ciforadenant [who-dd]
20. Schembl536782
21. Chembl4297184
22. Gtpl10190
23. Amy16758
24. Bcp20881
25. Ex-a1716
26. Bdbm50553404
27. Nsc801812
28. S6646
29. Who 10767
30. Akos037647889
31. Cs-7627
32. Nsc-801812
33. V81444;triazolo-pyramidine Derivative
34. As-75173
35. Hy-101978
36. D11547
37. A901713
38. (s)-7-(5-methylfuran-2-yl)-3-((6-((tetrahydrofuran-3-yloxy)methyl)pyridin-2-yl)methyl)-3h-[1,2,3]triazolo[4,5-d]pyrimidin-5-amine
39. 3-((6-(((s)-tetrahydrofuran-3-yloxy)methyl)pyridin-2-yl)methyl)-7-(5-methylfuran-2-yl)-3h-[1,2,3]triazolo[4,5-d]pyrimidin-5-amine
40. 7-(5-methylfuran-2-yl)-3-[(6-{[(3s)-oxolan-3-yloxy]methyl}pyridin-2-yl)methyl]-3h-[1,2,3]triazolo[4,5-d]pyrimidin-5-amine
| Molecular Weight | 407.4 g/mol |
|---|---|
| Molecular Formula | C20H21N7O3 |
| XLogP3 | 0.8 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 6 |
| Exact Mass | 407.17058756 g/mol |
| Monoisotopic Mass | 407.17058756 g/mol |
| Topological Polar Surface Area | 127 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 573 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
21
PharmaCompass offers a list of Ciforadenant API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ciforadenant manufacturer or Ciforadenant supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ciforadenant manufacturer or Ciforadenant supplier.
PharmaCompass also assists you with knowing the Ciforadenant API Price utilized in the formulation of products. Ciforadenant API Price is not always fixed or binding as the Ciforadenant Price is obtained through a variety of data sources. The Ciforadenant Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ciforadenant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ciforadenant, including repackagers and relabelers. The FDA regulates Ciforadenant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ciforadenant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ciforadenant supplier is an individual or a company that provides Ciforadenant active pharmaceutical ingredient (API) or Ciforadenant finished formulations upon request. The Ciforadenant suppliers may include Ciforadenant API manufacturers, exporters, distributors and traders.
Ciforadenant Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ciforadenant GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ciforadenant GMP manufacturer or Ciforadenant GMP API supplier for your needs.
A Ciforadenant CoA (Certificate of Analysis) is a formal document that attests to Ciforadenant's compliance with Ciforadenant specifications and serves as a tool for batch-level quality control.
Ciforadenant CoA mostly includes findings from lab analyses of a specific batch. For each Ciforadenant CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ciforadenant may be tested according to a variety of international standards, such as European Pharmacopoeia (Ciforadenant EP), Ciforadenant JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ciforadenant USP).
